BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24643277)

  • 21. Mammalian iRhoms have distinct physiological functions including an essential role in TACE regulation.
    Christova Y; Adrain C; Bambrough P; Ibrahim A; Freeman M
    EMBO Rep; 2013 Oct; 14(10):884-90. PubMed ID: 23969955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.
    Blaydon DC; Etheridge SL; Risk JM; Hennies HC; Gay LJ; Carroll R; Plagnol V; McRonald FE; Stevens HP; Spurr NK; Bishop DT; Ellis A; Jankowski J; Field JK; Leigh IM; South AP; Kelsell DP
    Am J Hum Genet; 2012 Feb; 90(2):340-6. PubMed ID: 22265016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhbdf2 mutations increase its protein stability and drive EGFR hyperactivation through enhanced secretion of amphiregulin.
    Hosur V; Johnson KR; Burzenski LM; Stearns TM; Maser RS; Shultz LD
    Proc Natl Acad Sci U S A; 2014 May; 111(21):E2200-9. PubMed ID: 24825892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE.
    Adrain C; Zettl M; Christova Y; Taylor N; Freeman M
    Science; 2012 Jan; 335(6065):225-8. PubMed ID: 22246777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains.
    Tang B; Li X; Maretzky T; Perez-Aguilar JM; McIlwain D; Xie Y; Zheng Y; Mak TW; Weinstein H; Blobel CP
    FASEB J; 2020 Apr; 34(4):4956-4969. PubMed ID: 32103528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex.
    Künzel U; Grieve AG; Meng Y; Sieber B; Cowley SA; Freeman M
    Elife; 2018 Jun; 7():. PubMed ID: 29897336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.
    Zheng X; Jiang F; Katakowski M; Zhang ZG; Lu QE; Chopp M
    Cancer Biol Ther; 2009 Jun; 8(11):1045-54. PubMed ID: 19395875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.
    Maretzky T; Zhou W; Huang XY; Blobel CP
    Oncogene; 2011 Feb; 30(5):611-8. PubMed ID: 20871631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response.
    Arcidiacono P; Webb CM; Brooke MA; Zhou H; Delaney PJ; Ng KE; Blaydon DC; Tinker A; Kelsell DP; Chikh A
    Nat Commun; 2018 Mar; 9(1):1021. PubMed ID: 29523849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic insight on the role of iRhom2-TNF-α-BAFF signaling pathway in various autoimmune disorders.
    Dwivedi SD; Shukla R; Yadav K; Rathor LS; Singh D; Singh MR
    Adv Biol Regul; 2024 May; 92():101011. PubMed ID: 38151421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging roles of rhomboid-like pseudoproteases in inflammatory and innate immune responses.
    Luo WW; Shu HB
    FEBS Lett; 2017 Oct; 591(20):3182-3189. PubMed ID: 28815577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17.
    Moreno-Càceres J; Caja L; Mainez J; Mayoral R; Martín-Sanz P; Moreno-Vicente R; Del Pozo MÁ; Dooley S; Egea G; Fabregat I
    Cell Death Dis; 2014 Jul; 5(7):e1326. PubMed ID: 25032849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin Barrier Defects Caused by Keratinocyte-Specific Deletion of ADAM17 or EGFR Are Based on Highly Similar Proteome and Degradome Alterations.
    Tholen S; Wolf C; Mayer B; Knopf JD; Löffek S; Qian Y; Kizhakkedathu JN; Biniossek ML; Franzke CW; Schilling O
    J Proteome Res; 2016 May; 15(5):1402-17. PubMed ID: 27089454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
    Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
    J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. iRhom2 regulates CSF1R cell surface expression and non-steady state myelopoiesis in mice.
    Qing X; Rogers L; Mortha A; Lavin Y; Redecha P; Issuree PD; Maretzky T; Merad M; McIlwain D; Mak TW; Overall CM; Blobel CP; Salmon JE
    Eur J Immunol; 2016 Dec; 46(12):2737-2748. PubMed ID: 27601030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory activation of surface molecule shedding by upregulation of the pseudoprotease iRhom2 in colon epithelial cells.
    Giese AA; Babendreyer A; Krappen P; Gross A; Strnad P; Düsterhöft S; Ludwig A
    Sci Rep; 2021 Dec; 11(1):24230. PubMed ID: 34930929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the sheddase activity of ADAM17 by an anti-ADAM17 antibody D1(A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs transactivation.
    Huang Y; Benaich N; Tape C; Kwok HF; Murphy G
    Int J Biol Sci; 2014; 10(7):702-14. PubMed ID: 25013379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling.
    Qing X; Chinenov Y; Redecha P; Madaio M; Roelofs JJ; Farber G; Issuree PD; Donlin L; Mcllwain DR; Mak TW; Blobel CP; Salmon JE
    J Clin Invest; 2018 Apr; 128(4):1397-1412. PubMed ID: 29369823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
    Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.
    Issuree PD; Maretzky T; McIlwain DR; Monette S; Qing X; Lang PA; Swendeman SL; Park-Min KH; Binder N; Kalliolias GD; Yarilina A; Horiuchi K; Ivashkiv LB; Mak TW; Salmon JE; Blobel CP
    J Clin Invest; 2013 Feb; 123(2):928-32. PubMed ID: 23348744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.